StockData
PepGen Inc. logo

PepGen Inc. (PEPG) stock

PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.83−0.05 (-1.29%)

Close on Nov 18, 2026Market cap $265.26MP/E –Yield –

PepGen free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

PepGen's free cash flow for the twelve months ending Jun 30, 2026 was -$69.46M. For fiscal 2025 it was -$81.90M. The highest annual figure on record is -$23.10M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$81.90M–
FY2024Dec 31, 2024-$82.87M–
FY2023Dec 31, 2023-$71.60M–
FY2022Dec 31, 2022-$63.02M–
FY2021Dec 31, 2021-$23.10M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.84M–
Q1 FY2026Mar 31, 2026-$18.43M–
Q4 FY2025Dec 31, 2025-$15.84M–
Q3 FY2025Sep 30, 2025-$19.36M–
Q2 FY2025Jun 30, 2025-$23.64M–
Q1 FY2025Mar 31, 2025-$23.06M–
Q4 FY2024Dec 31, 2024-$19.70M–
Q3 FY2024Sep 30, 2024-$24.20M–
Q2 FY2024Jun 30, 2024-$16.38M–
Q1 FY2024Mar 31, 2024-$22.59M–
Q4 FY2023Dec 31, 2023-$19.61M–
Q3 FY2023Sep 30, 2023-$16.91M–
Q2 FY2023Jun 30, 2023-$18.48M–
Q1 FY2023Mar 31, 2023-$16.60M–
Q4 FY2022Dec 31, 2022-$14.49M–
Q3 FY2022Sep 30, 2022-$21.40M–
Q2 FY2022Jun 30, 2022-$13.25M–
Q1 FY2022Mar 31, 2022-$13.89M–
Q4 FY2021Dec 31, 2021-$6.14M–
Q3 FY2021Sep 30, 2021-$7.67M–
Q2 FY2021Jun 30, 2021-$6.15M–
Q1 FY2021Mar 31, 2021-$3.14M–

More PepGen figures

See a number that looks wrong?